Brief: AFT Pharmaceuticals Targets FY27 Revenue Above NZ$300 Mln
20/05/2026 21:55
May 21 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ: TARGETING NZ$300 MILLION PLUS REVENUE FOR FY27 FY27 GUIDANCE FOR INCREASED OPERATING PROFIT OF NZ$28 MILLION TO NZ$32 MILLION Further company coverage: AFT.NZ ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV